Atorvastatin Calcium Tablet
Product Images NDC 70518-3783

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70518-3783). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Atorvastatin Calcium 20 mg tablet label showing quantity of 30 tablets. The label includes RX Only, NDC number 70518-3783-00, manufacturer information for Nivagen Pharmaceuticals, and repackager RemedyRepack Inc. It advises storage at 20-25°C and refers to the package insert for directions.*

FDA Label Image

Image Description (Atorvastat Cal Usp Fig 1)

A line graph showing cumulative incidence percentage over 3.5 years comparing Atorvastatin and placebo groups. The graph includes two lines: a solid line for Atorvastatin and a dashed line for placebo, with Atorvastatin demonstrating a lower cumulative incidence. The hazard ratio (HR) is indicated as 0.64 with a confidence interval and a p-value of 0.0005.*

FDA Label Image

Image Description (Atorvastat Cal Usp Fig 2)

A Kaplan-Meier curve showing cumulative hazard over time comparing Atorvastatin and Placebo groups through four years of follow-up. The x-axis represents time in years, and the y-axis represents cumulative hazard in percentage. Atorvastatin has a lower cumulative hazard than Placebo, with a hazard ratio (HR) of 0.63 and a p-value of 0.001.*

FDA Label Image

Image Description (Atorvastat Cal Usp Fig 3)

A line graph showing the percentage of subjects experiencing a cardiovascular event over time, comparing Atorvastatin 10 mg (dashed line) and Atorvastatin 80 mg (solid line) across five years. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects. A hazard ratio of 0.78 with confidence interval (0.69-0.89) and a P-value of 0.0002 is indicated.*

FDA Label Image

Image Description (Atorvastat Cal Usp Structure)

Chemical structure diagram of Atorvastatin calcium showing its molecular configuration including rings, functional groups, and calcium ion complexation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.